Welcome to the December 2022 edition of the HealthTech Activator (HTA) Monthly Wrap. Before we dive in, the team would like to thank you for joining us throughout 2022 and we wish you all the best for a happy holiday season!
In this month’s HTA blog, Alimetry’s Odette Lees discusses the benefits of applying for healthtech innovation programmes and awards, including the MedTech Innovator APAC and Medtronic APAC Innovation Challenge, and why every startup should consider doing the same.
You’ll find links to healthtech challenges (including the two mentioned above) on the HTA directory. Joined a challenge or competition that you think other NZ startups would find useful? Let us know and we’ll add it to the list.
2023 is fast approaching, and you can find all upcoming events on the HTA website. The first events will be in March and are open for signups now — if you’re keen to get in early.
Read on for more information and links to sector news from the past month, and if you have any comments or suggestions to improve this newsletter, we would love to hear from you! As always, thanks for subscribing to the HTA.
HTA news
Do the mahi, get the treats…then do better mahi!
Odette Lees, Business Intelligence Manager at Alimetry
In this month’s HTA blog, Odette Lees discusses how Alimetry, an award-winning NZ healthtech startup, has benefitted from participating in a variety of competitions on its commercialisation journey, including involvement in two recent international challenges.
2 March 2023, Auckland | Facilitated by Annett Arndt of Johner Institute
The HTA and Te Tītoki Mataora are pleased to host our first workshop on the regulation requirements for software as a medical device (SaMD) products. This workshop is an introduction to the topic of development, quality assurance and approval of medical software (SaMD or medical device software).
Hosted at the Auckland Bioengineering Institute, this event is open to companies and research groups - with specific HTA tickets available for companies when registering.
9 March 2022, online | Facilitated by Tim McCready of BioPacific Partners
This interactive, online workshop is an introduction to the challenges of capital raising, with a focus on healthtech companies. We encourage early to mid-stage healthtech companies seeking to raise capital for the first time (outside their immediate networks) to attend.
PDH, a public-private partnership between Orion Health, Te Whatu Ora and University of Auckland, has released a report on their achievements since being founded in 2016 (29 November: HiNZ).
A new bedside troponin test that provides a result in minutes, potentially saving hours of ED time, is being rolled out across NZ in 2023 after initial success in Christchurch (30 November: NZ Herald).
Diagnostics company Pictor has announced a $5m capital raise, with an eye on attracting international investment for launching their human and animal health products (5 December: NBR)
The Insides Company has a pending offer on Snowball Effect and has raised $1m from existing investors, with one device on the market and two more in development (8 December: NBR).
Ubiquitome receives FDA emergency use approval for its real time PCR system, Liberty16 Pro, for use with the Yale School of Public Health SalivaDirect SARS-CoV-2 test (19 December: BusinessWire).
.png?upscale=true&width=1120&upscale=true&name=News%20(1).png)
